Orthologous Cross-Species  Microarrays

Cross-species Genomics (CrossGen®) Limited is a recently formed company using proprietary CGH microarray technology to provide a unique service to the pharmaceutical industry. We develop orthologous microarrays for species with less well-characterised genomes. Our microarrays are particulaly useful for toxicology studies in early pre-clinical trials. They can also be used for the development of veterinary pharmaceuticals and the identification of surrogate markers.

Using comparative genome hybridisation technology orthologous GeneChip probes are selected to construct a microarray for unsequenced genomes. The cross-species array is compatible to the Affymetrix GeneChip system hence no further costs in equipment is required in order to process our cross-species arrays. The arrays enable robust data analysis due to elimination of low signals as a result of genetic variability between species.